• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 CRAGG-MCNAMARA; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 CRAGG-MCNAMARA; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number 41057-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Pseudoaneurysm (2605)
Event Date 01/01/1993
Event Type  Injury  
Manufacturer Narrative
Lee d, waldman d, sumida r, green r.Direct graft puncture with use of a crossed catheter technique for thrombolysis of peripheral bypass grafts.Jvir 2000; 11:445¿ 452.Doi: 10.1016/s1051-0443(07)61376-1.Reported patient age (70 years) is representative of the average age of all patients included in the study.Reported patient sex (male) is representative of the majority of patients included in the study.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Lee d, waldman d, sumida r, green r.Direct graft puncture with use of a crossed catheter technique for thrombolysis of peripheral bypass grafts.Jvir 2000; 11:445¿ 452.Doi: 10.1016/s1051-0443(07)61376-1.The purpose of this article was to determine the efficacy and safety of direct graft puncture of peripheral arterial bypass grafts with placement of retrograde and antegrade catheters within the graft for thrombolytic therapy.This study also evaluated potential clinical benefit to patients.The authors reviewed 19 patients with 24 peripheral bypass grafts and lower extremity ischemia of less than 1 month duration.Thrombolysis was performed with a continuous high-dose infusion of urokinase.Successful lysis was defined as greater than 95% clot dissolution with antegrade flow within the graft.In five cases, a mewissen catheter (boston scientific vascular, (b)(4)) was used for infusion.The remainder utilized craggmcnamara infusion catheters (mti, (b)(4)), which were placed across both anastomoses.In 10 of 19 (52%) patients, the catheter was left proximal to the distal anastomosis because of an inability to cross the anastomosis with a guide wire (six of nine), or concern that the catheter would occlude a stenotic anastomosis (four of 19).Arterial sheaths (5¿ 6 f) were placed in 11 of 19 (58%) at the discretion of the interventional radiologist.The remainder of cases (eight of 19) had only the infusion catheters left in place.In our study, there was one death that occurred during hospitalization.This patient died approximately 3 weeks after the procedure of a hospital-acquired pneumonia that occurred 2 weeks after surgery.Of the 19 patients, the average age was 70 years, there were 6 women and 13 men.The following intra- or post-procedural outcomes were noted: 1.Hemorrhage 2/19 (11%) 2.Pseudoaneurysm 1/19 (5%) 3.Hematoma 1/19 (5%) 4.Death due to pneumonia 1/19.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRAGG-MCNAMARA
Type of Device
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key14292009
MDR Text Key294656322
Report Number2029214-2022-00773
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 05/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number41057-01
Device Catalogue Number41057-01
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/06/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient SexMale
-
-